生物科技高階管理碩士專班

Medicine & Life Sciences

1. Taiwan 100%
2. Confidence Intervals 52%
3. Cohort Studies 47%
4. Neoplasms 43%
5. Propensity Score 40%
6. Population 37%
7. Bariatric Surgery 36%
8. National Health Programs 36%
9. Apoptosis 35%
10. Odds Ratio 35%
11. Dioscorea 35%
12. Cell Movement 34%
13. Mortality 34%
14. alkannin 31%
15. Colonic Neoplasms 28%
16. Weight Loss 26%
17. Hepatocellular Carcinoma 26%
18. Case-Control Studies 25%
19. osthol 25%
20. Peroxisome Proliferator-Activated Receptors 25%
21. shikonin 25%
22. Stomach 25%
23. Gastric Bypass 24%
24. Health 24%
25. Colorectal Neoplasms 23%
26. Proteins 23%
27. Elderly 23%
28. Delivery of Health Care 22%
29. Chronic Renal Insufficiency 21%
30. 15-deoxy-delta(12,14)-prostaglandin J2 20%
31. Gastrectomy 20%
32. Databases 20%
33. In Vitro Techniques 20%
34. Osteoblasts 20%
35. JNK Mitogen-Activated Protein Kinases 20%
36. Stomach Neoplasms 19%
37. Genes 19%
38. Squamous Cell Carcinoma 19%
39. Logistic Models 19%
40. WJ1376-1 19%
41. WJ1398-1 19%
42. Retrospective Studies 19%
43. Stroke 18%
44. Body Mass Index 18%
45. Nitric Oxide 17%
46. Chitosan 16%
47. Data Mining 16%
48. Phosphorylation 16%
49. Antioxidants 16%
50. Methanol 16%
51. High Fat Diet 16%
52. Blood Pressure 16%
53. Down-Regulation 16%
54. glucose-regulated proteins 16%
55. Laparoscopy 16%
56. Liver 16%
57. Gene Expression 16%
58. Therapeutics 16%
59. 15,16-dihydrotanshinone I 16%
60. Vitis 16%
61. Gallbladder Diseases 15%
62. Morbid Obesity 15%
63. Rectal Neoplasms 15%
64. Liver Cirrhosis 15%
65. Antihypertensive Agents 15%
66. Appendectomy 15%
67. Mitral Valve Prolapse 15%
68. Physicians 15%
69. Obesity 14%
70. Lipopolysaccharides 14%
71. Macrophages 14%
72. Liver Neoplasms 14%
73. Cell Proliferation 14%
74. Triple Negative Breast Neoplasms 13%
75. Colon 13%
76. Genistein 13%
77. Kidney Diseases 13%
78. HL-60 Cells 13%
79. Kenya 13%
80. Randomized Controlled Trials 13%
81. Health Expenditures 13%
82. Polygonum 13%
83. Latent Class Analysis 13%
84. Growth 12%
85. Phosphotransferases 12%
86. Endothelial Cells 12%
87. sanguinarine 12%
88. Parkinson Disease 12%
89. Nicotinic Receptors 12%
90. magnolol 12%
91. Glucose 12%
92. Water 12%
93. Non-alcoholic Fatty Liver Disease 12%
94. Nicotine 12%
95. Erectile Dysfunction 12%
96. Propofol 12%
97. Inflammation 12%
98. Comorbidity 12%
99. Chronic Kidney Failure 12%
100. Costs and Cost Analysis 12%

Chemical Compounds

1. Protein 27%
2. Alkannin 27%
3. Osthole 26%
4. Shikonin 25%
5. Apoptotic 19%
6. Antioxidant Agent 18%
7. Glucose 17%
8. Blood Pressure 14%
9. Alloy 13%
10. Resveratrol 12%
11. Chitosan 12%
12. Drug 12%
13. Surface 11%
14. Nitric Oxide 11%
15. Hypertensive 11%
16. Antidiabetic Agent 11%
17. Implant 10%
18. Fluidization 10%
19. Lipopolysaccharide 10%
20. Methanol 9%
21. Antihypertensive 9%
22. Time 9%
23. Genotoxicity 9%
24. Weight 9%
25. Bioceramic 9%
26. Machining 9%
27. Enantiomer 8%
28. Plasma 8%
29. Glycine Hydroxamate 8%
30. Nanocarrier 8%
31. Dipeptide 7%
32. Liposome 7%
33. Disorder 7%
34. Cabozantinib 7%
35. Fluorometholone 7%
36. Triglyceride 7%
37. Retinal 7%
38. Heme 7%
39. Geraniin 6%
40. 1,2-dioxane 6%
41. Cantharidin 6%
42. Econazole 6%
43. Dose 6%
44. Permeability 6%
45. Application 6%
46. Cytometry 6%
47. Terbinafine 6%
48. Isoorientin 6%
49. Terfenadine 6%
50. Hypercholesterolemic 6%
51. Naphthazarin 6%
52. Microstructure 6%
53. Magnolol 6%
54. Thrombin 6%
55. Poly(I:C) 6%
56. Aristolochic Acid 6%
57. Rosiglitazone 6%
58. Photooxidation 5%
59. Reactive Oxygen Metabolite 5%
60. Propofol 5%
61. Miconazole 5%
62. Dextromethorphan 5%
63. Sinapic Acid 5%
64. Hemodynamic 5%
65. Griseofulvin 5%
66. Embossing 5%
67. Water Soluble 5%
68. Ligand 5%
69. Decomposition 5%
70. Podophyllotoxin 5%
71. Quercetin 5%
72. Hydrocarbon 5%
73. Galacturonic Acid 5%
74. Prednisolone 5%
75. Poloxamer 5%
76. Catalytic Pyrolysis 5%
77. Bone Substitute 5%
78. Ketoconazole 5%
79. Prostaglandin J2 5%
80. Phosphoinositide 5%
81. Liquid Film 5%
82. Antitumor 5%
83. Surfactant 5%
84. Aluminium Nitride 5%
85. Genistein 5%
86. Chemotactic 5%
87. Ampholyte 5%
88. Metallic Glass 5%